DAIRY INDUSTRY BGH COVERUP
What every breeder (and parent)
should know about BGH milk, dairy products, and
beef: health problems the media won’t
reveal.
Reproductive problems, compromised
immune systems, low-grade infections,
poor response to proven antibiotics,
just some of the health problems
attributed to consumption of
hormone-laden milk, dairy products, and
pet food containing this category of DDD
(Dead, Diseased, Dying) beef.
Here is the shocking story the news
media has withheld from you. The health
problems will enlighten you, the extent
of the cover-up will frighten you, and
learning that the Animal Rights groups
won’t address it will infuriate you!
BOVINE GROWTH HORMONE-BGH FACTS
-
Genetically engineered copy of a
cow’s natural growth hormone
injected into dairy cows to increase
milk production
-
Injected into cattle intended for
slaughter to accelerate growth
-
Causes Mastitis, a potentially fatal
mammary gland infection in dairy
cows, resulting in pus and
antibiotic pass-through in milk
-
Believed to be responsible for over
40% reduction in fertility,
lameness, open sores and fatalities
from internal bleeding
-
Passed to humans through milk and
beef products
-
Passed to dogs and cats in pet foods
containing beef
-
Believed to pose endocrine cancer
risk and other health problems to
humans who ingest the hormone-laden
milk and beef products
Monsanto’s genetically engineered bovine
growth hormone (trade name
Posilac) was FDA approved in
1994. The
U.S. is the only country that allows use
of this hormone! Even more
shocking is that not only did the FDA
not require labeling on consumer
products, FDA refused to
allow BGH-free labeling! [1] Do not miss the
“prescription insert” label in end
notes. Read and then call on HSUS, PETA,
ASPCA, etc. to stop the relentless,
deadly animal cruelty! Or… read
why the press doesn’t run this story and
form your own opinion about why the
animal rights people fail to address
this ongoing, daily cruelty to animals.
In 1987, Monsanto submitted a new animal
drug application for Posilac, a
synthetic growth hormone to increase
milk production in dairy cows. If BGH,
aka recombinant bovine somatotropin (rBST)
and recombinant bovine growth hormone (rBGH)
sounds futuristic and frightening, it
is. Nonetheless, Monsanto supplemented
the application with studies and reports
documenting the safety and effectiveness
of the drug. After reviewing those
materials for 6 years, the FDA approved
the use of the synthetic bovine growth
hormone in 1993 and in January 1994, a
Congressional task force concluded that
the FDA’s position regarding labeling
was adequately supported on the basis
that there was no difference in treated
and untreated cow's milk. They ruled
therefore that there should be no
labeling to indicate a difference.
The integrity of scientists and
university members was believed
compromised by pressures from Monsanto;
therefore the truth was withheld from
consumers and mainstream media did not
report on BGH.
“Whistleblower” scientists and
journalists’ investigations on health
problems caused by BGH were suppressed.
Even the Fox News Network eliminated
both the story and the journalists after
83 rewrites covering the truth about BGH!
[2] Unquestionably, “BGH
Milk” is among the USA’s most egregious
cover-ups involving consumers, the drug
industry, and food producers.
Sick and dying cows went to slaughter
houses where their remains went straight
into pet foods. Thus the DDD term
“Dead, Diseased, or Dying” because FDA
allows “meat unfit for human
consumption” to be used for pet food.
Due to the massive cover-up, no pet
health problems were diagnosed or
directly traced to BGH. Until now.
Ironically, many herdsmen claim the
recombinant rBHG, trade name Posilac,
never lived up to Monsanto’s claim that
it would stimulate milk production and
in some cases production diminished.
Worst of all, losing cows (many with
pedigrees longer than your Best In Show
winner) was financially and emotionally
devastating to generational family dairy
farmers.
|
Monsanto’s rBGH was rejected
by Canada, Japan, Australia,
New Zealand, and the
European Union (consisting
of 27 countries), but Eli
Lilly has begun a campaign
to market their newly
purchased recombinant bovine
growth hormone. |
Monsanto had the deep pockets needed
to influence the
networks and skew
the data from university studies but
after 5 years of controversy,
Monsanto sold Posilac to a
key member of the drug empire.
[3] The buyer, Elanco Animal
Health, a division of the
Eli Lilly Company, seems just as
willing to put profit before health.
